Wenjin Hu

Title: Innovations of Wenjin Hu in Antibody Development

Introduction

Wenjin Hu is a notable inventor based in Jiangsu, China, recognized for his contributions to the field of antibody development. He holds three patents that focus on innovative solutions for detecting and analyzing viral infections, particularly influenza A and SARS-CoV-2.

Latest Patents

Wenjin Hu's latest patents include a nanobody targeting influenza A virus nucleoprotein and its application. This invention involves the construction of a nanobody phage library and phage screening technology to obtain a nanobody that specifically binds to the influenza A virus nucleoprotein. The nanobody has significant potential for use in early warning systems for influenza outbreaks and environmental detection. Another significant patent is the preparation method and application of a single-chain antibody fragment targeting the SARS-CoV-2 nucleocapsid protein. This invention also utilizes phage screening technology to develop single-chain antibody fragments with high affinity and specificity for SARS-CoV-2 detection.

Career Highlights

Wenjin Hu is affiliated with Nanjing University, where he continues to advance research in the field of immunology and antibody development. His work has garnered attention for its practical applications in public health and disease prevention.

Collaborations

Wenjin Hu collaborates with notable colleagues, including Yi Luo and Shixiang Yang, who contribute to his research endeavors and innovations in antibody technology.

Conclusion

Wenjin Hu's innovative work in developing nanobodies and single-chain antibody fragments represents a significant advancement in the detection of viral infections. His contributions have the potential to enhance public health responses to viral outbreaks.